Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone von Kundu, Juthika, Le, Hoa T., Logan, Michael, Hockman, Darren, Landi, Abdolamir, Crawford, Kevin, Wininger, Mark, Johnson, Janelle, Kundu, Joydeb K., Tiffney, E. Alana, Urbanowicz, Richard A., Ball, Jonathan K., Bailey, Justin R., Bukh, Jens, Law, Mansun, Foung, Steven, Tyrrell, D. Lorne, Houghton, Michael, Law, John Lokman

Volltext

Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis von Kanai, Tapan, Hu, Zongyi, Yang, Renbin, Wu, Weimin, Wang, Ziqiu, Ma, Christopher D, Sanchez-Meza, Jaime, Law, Mansun, Houghton, Michael, Law, John Lokman, Logan, Michael, de Val, Natalia, Liang, T Jake

Volltext

An Inactivated Hepatitis C Virus Vaccine on the Horizon? von Houghton, Michael, Law, John Lokman, Tyrrell, D. Lorne

Volltext

A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans. e59776 von Law, John LokMan, Chen, Chao, Wong, Jason, Hockman, Darren, Santer, Deanna M, Frey, Sharon E, Belshe, Robert B, Wakita, Takaji, Bukh, Jens, Jones, Christopher T

Volltext